Clinics in Mississippi
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
What Mississippi law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and listings with their verification status.
Mississippi at a glance
- Pharmacy regulator
- Mississippi Board of Pharmacy
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async not allowed
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Clinics serving Mississippi
No verified clinics serving Mississippi are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.
Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.
Run a pharmacy, clinic, or telehealth service? Apply for a listing.
Peptide access rules in Mississippi
Yes. A Mississippi resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a physician or physician assistant with an unrestricted Mississippi license, including by telemedicine under the Board of Medical Licensure's telemedicine rule (Miss. Admin. Code Title 30, Part 2635, Chapter 5), which requires an unrestricted Mississippi license, a valid physician-patient relationship, and a real-time interaction with the provider. A questionnaire alone is not enough. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy permitted by the Mississippi Board of Pharmacy; out-of-state pharmacies need a nonresident permit under Miss. Code section 73-21-106 and must use a pharmacist-in-charge who also holds a Mississippi pharmacist license. The Board has issued guidance rejecting compounded semaglutide made from salt forms. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10]
Compounded GLP-1 access in Mississippi
A telehealth GLP-1 program must use a physician or physician assistant with an unrestricted Mississippi license and a pharmacy holding a Mississippi permit or nonresident permit. The Board of Medical Licensure's telemedicine rule requires a real-time interaction with the provider, so a questionnaire alone does not support a prescription. [3] [5] [6] [9] [11]
Research use only sellers in Mississippi
The Mississippi Pharmacy Practice Act limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so sellers of "research use only" injectable peptides to Mississippi consumers are not lawful dispensers in the state. On August 19, 2026 the Mississippi State Board of Medical Licensure, Board of Nursing, and Board of Pharmacy issued a joint statement that no healthcare provider may compound, administer, dispense, prescribe, advise on, recommend, or supply a non-FDA-approved or research-grade peptide, or delegate those acts to another provider. The boards said a patient consent form calling a product research grade does not remove the provider's professional or legal liability, and providers must buy all prescription products, drugs, and ingredients from entities permitted by the Mississippi Board of Pharmacy. [1] [6] [8] [12] [13]
Mississippi notes on specific peptides
- Semaglutide: Available branded by prescription from a physician or physician assistant with an unrestricted Mississippi license, including by telemedicine with a real-time interaction (audio-visual, or audio only where medically appropriate) under Board Rule 5.5; a questionnaire alone is not enough. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025, and the Mississippi Board of Pharmacy has said salt forms such as semaglutide sodium or acetate may not be used. [5] [9] [11]
How to check a clinic in Mississippi
- Confirm the prescribing clinician's license with the Mississippi medical or nursing board.
- Ask which pharmacy compounds or dispenses the peptide and check it in the Mississippi Board of Pharmacy license lookup. [1] [6] [7] [8] [9] [10]
- Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Mississippi. [1] [6] [8] [12] [13]
Common questions in Mississippi
Can I get a GLP-1 prescription in Mississippi through telemedicine?
Yes, from a physician with a Mississippi license who establishes a valid physician-patient relationship under the Board of Medical Licensure's telemedicine rule. The rule requires a real-time interaction, by audio and video or by audio only where medically appropriate, and says a simple questionnaire without an appropriate exam violates it. Semaglutide and tirzepatide are not controlled substances. [3] [4] [5]
Sources
- [1]Mississippi Board of Pharmacy
- [2]Mississippi State Board of Medical Licensure: administrative code (June 2025 compilation)
- [3]Miss. Admin. Code Title 30, Part 2635, Chapter 5, Practice of telemedicine (rule 5.1 definitions)
- [4]Miss. Admin. Code Title 30, Part 2635, Rule 5.4, Physician patient relationship
- [5]Miss. Admin. Code Title 30, Part 2635, Rule 5.5, Examination
- [6]Miss. Code section 73-21-106, Registration requirement for nonresident pharmacies
- [7]Mississippi House Bill 856, 2025 Regular Session (as sent to Governor): reenacts section 73-21-106 and extends the Pharmacy Practice Act repealer to July 1, 2029
- [8]Mississippi Pharmacy Practice Regulations (Title 30, Part 3001)
- [9]Mississippi Board of Pharmacy: semaglutide compounding guidance
- [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA